News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
November 3, 2025
·
5 min read
Press Releases
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
November 3, 2025
·
1 min read
Press Releases
Britannia Life Sciences Inc. Enters into $11.3 Million Share Exchange Agreement with McEwen Inc. and Britannia Mining Solutions Inc.
November 3, 2025
·
4 min read
Press Releases
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
October 31, 2025
·
4 min read
Press Releases
PharmaDrug Announces Debt Restructuring
October 31, 2025
·
5 min read
Press Releases
Anne-Kathrin Stoller to Become New CEO at Bachem
October 31, 2025
·
3 min read
Press Releases
Hemostemix’s Boots on the Ground in Florida October Update
October 30, 2025
·
9 min read
Press Releases
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
October 30, 2025
·
8 min read
Press Releases
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis
October 30, 2025
·
10 min read
Press Releases
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
October 30, 2025
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us